Last updated: January 15, 2024
Sponsor: University Children's Hospital, Zurich
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hiv Infections
Primary Immunodeficiency Disorders
Treatment
blood sampling
blood sampling and skin biopsy
blood sampling or mouth swap
Clinical Study ID
NCT02735824
GSI KEK_2015-0555
All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patient with suspected PID, healthy relative or healthy volunteer
- consent
Exclusion
Exclusion Criteria:
- none
Study Design
Total Participants: 500
Treatment Group(s): 3
Primary Treatment: blood sampling
Phase:
Study Start date:
February 01, 2016
Estimated Completion Date:
December 31, 2027
Study Description
Connect with a study center
Division of Immunology
Zurich, ZH 8032
SwitzerlandActive - Recruiting
University of Basel Children's Hospital
Basel, 4031
SwitzerlandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.